Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ovarian cancer
ovarian cancer
GSK drug helps ovarian cancer patients live longer in late-stage study
Yahoo/Reuters
Mon, 07/15/19 - 09:59 am
GSK
Zejula
ovarian cancer
clinical trials
GSK wins speedy FDA Zejula review in ovarian cancer niche
Fierce Pharma
Mon, 06/24/19 - 07:13 pm
GSK
FDA
Zejula
ovarian cancer
late-stage ovarian cancer
Tesaro
AstraZeneca's Lynparza gets EU nod as first-line ovarian cancer maintenance treatment
Yahoo/Reuters
Tue, 06/18/19 - 10:04 am
AstraZeneca
Lynparza
ovarian cancer
Europe
Can a little known drug in AstraZeneca's pipeline make a comeback as a PARP add-on? Yale scientists explain how
Endpoints
Thu, 05/16/19 - 11:51 am
AstraZeneca
cediranib
ovarian cancer
Yale
PARP inhibitors
FDA tells ImmunoGen to run a second phase 3, sinking stock
Fierce Biotech
Wed, 05/15/19 - 10:38 am
Immunogen
mirevtuximab soravtansine
ovarian cancer
clinical trials
Lynparza on cusp of EU approval for advanced ovarian cancer
Pharmaforum
Mon, 04/29/19 - 10:28 am
AstraZeneca
Lynparza
Europe
CHMP
ovarian cancer
Clovis Focuses on Rubraca Label Expansion, Competition Stiff
Yahoo/Zacks.com
Thu, 04/18/19 - 10:25 pm
Clovis Oncology
Rubraca
ovarian cancer
After ovarian cancer flop, PharmaMar's lurbinectedin makes the cut in small cell lung cancer
Endpoints
Mon, 03/25/19 - 10:19 am
PharmaMar
ovarian cancer
lurbinectedin
relapsed small cell lung cancer
small cell lung cancer
Novocure launches pivotal ovarian cancer trial
Drug Delivery Business News
Fri, 03/22/19 - 10:19 am
Novocure
devices
ovarian cancer
platinum-resistant ovarian cancer
clinical trials
tumor treating fields
Pfizer, Merck KGaA throw in the towel on another Bavencio PhIII as once bright hopes shrivel fast
Endpoints
Tue, 03/19/19 - 08:22 pm
Pfizer
Merck KGaA
ovarian cancer
Bavencio
ImmunoGen Plunges After Phase III Ovarian Cancer Treatment Fails to Hit PFS Endpoint
BioSpace
Fri, 03/1/19 - 10:16 am
Immunogen
ovarian cancer
clinical trials
mirvetuximab soravtansine
AI Picks Out 'Shapeshifting' Cancer Cells, Revealing Potential New Drug Targets
Forbes
Tue, 01/15/19 - 11:19 am
artificial intelligence
ovarian cancer
diagnostics
Bavencio fails second ovarian cancer Phase III trial
BioCentury
Fri, 12/21/18 - 11:07 pm
Merck KGaA
Bavencio
ovarian cancer
Judge refuses to overturn $4.7 billion talc powder verdict
Yahoo/AP
Thu, 12/20/18 - 11:47 pm
JNJ
ovarian cancer
Merck KGaA and Pfizer say drug failed to meet primary endpoints in late-stage ovarian cancer trial
Marketwatch
Mon, 11/19/18 - 09:59 am
Merck KGaA
Pfizer
avelumab
ovarian cancer
clinical trials
FDA Accepts sNDA for Lynparza for Maintenance Therapy in Advanced Ovarian Cancer and Grants Priority Review
CP Wire
Mon, 11/12/18 - 10:19 am
Lynparza
Merck
AstraZeneca
ovarian cancer
FDA
FDA Accepts sNDA for Lynparza for Maintenance Therapy in Advanced Ovarian Cancer and Grants Priority Review
Mon, 11/12/18 - 09:54 am
Lynparza
Merck
AstraZeneca
ovarian cancer
PARP makers search for a way to break through
Biopharma Dive
Fri, 11/9/18 - 12:08 am
AstraZeneca
Clovis Oncology
Tesaro
PARP inhibitors
ovarian cancer
MaxCyte begins dosing in phase I solid tumors clinical trial
Pharmaceutical Business Review
Thu, 10/11/18 - 09:41 am
MaxCyte
MCY-M11
relapsed/refractory ovarian cancer
ovarian cancer
peritoneal mesothelioma
solid tumors
Carrick bags ex-Onyx cancer drug, plans pivotal trials
Fierce Biotech
Thu, 10/11/18 - 09:27 am
ovarian cancer
Carrick
Onyx
CT900
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »